Name: UMIN ID:
Unique ID issued by UMIN | UMIN000030139 |
---|---|
Receipt number | R000034416 |
Scientific Title | Double-Blind, parallel-group comparison, investigators initiated phase II clinical trial of IDEC-C2B8 (Rituximab) in patients with Systemic Sclerosis |
Date of disclosure of the study information | 2017/11/28 |
Last modified on | 2020/09/29 20:40:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/11/27 19:46:10 | ||
2 | Update | 2017/11/27 22:21:28 | Acronym Acronym |
|
3 | Update | 2018/01/18 16:44:26 | Recruitment status |
|
4 | Update | 2018/01/18 16:57:30 | Organization Organization Organization Co-sponsor Co-sponsor Name of secondary funder(s) Name of secondary funder(s) |
|
5 | Update | 2018/11/29 13:46:51 | Key inclusion criteria Key inclusion criteria |
|
6 | Update | 2018/11/29 13:49:20 | Recruitment status |
|
7 | Update | 2019/04/01 07:19:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code TEL Organization Organization Address Address Tel |
|
8 | Update | 2019/05/29 11:51:38 | Email1 |
|
9 | Update | 2019/11/06 11:51:10 | Acronym Scientific Title:Acronym |
|
10 | Update | 2020/09/29 20:40:20 | Recruitment status Date of IRB Last follow-up date |